{"name":"Radionetics Oncology","slug":"radionetics-oncology","ticker":"","exchange":"","domain":"radioneticsoncology.com","description":"Radionetics Oncology is a biotechnology company focused on the development of innovative radiopharmaceuticals for the treatment of cancer. The company's pipeline includes five drugs in early-stage clinical trials, primarily targeting oncology indications.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOa0FEYml3N0gxZHB5OEltZS1CXzBPeVJnZjdMcWZMSklkRUh5UXBkUEZTRmRFQnVmLW5hTmNPbXBPel9ucmhtRkxzVEEtOUJTckRtbHlXNlpmQmRjdVJfMll6RVZYb1Y1MHJHMTNJSWwwbVo0RmlPa2QxZE55ZmExVnJpbDdzVDhoVXhsbk9mTUlndGZaMUE?oc=5","date":"2024-07-08","type":"pipeline","source":"San Diego Business Journal","summary":"Eli Lilly & Co. Options Radionetics for $1B - San Diego Business Journal","headline":"Eli Lilly & Co. Options Radionetics for $1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOS2J5NUxSYllhMDRPOUNKSEpqNHpGZ3JnVGpBbnlRY0hvWXNqYllPa0h1ZzVoNmhJV2JQV3Y5ZkRkbVloeFZtbUZlRUlaLWlBaTVZSFlBUVg0X25VNGhvdkI0Ujc3LWJjS2dDbm45OVNFZ3BUZFV2Y3ZiSllIOU5qbnVNdmxoclN1cnBFalVUZUNLN3BRUkpRTUdfeThVQTFRNmFDZ2RaREV4ay1BMmRQTkxBMEcwUms?oc=5","date":"2024-07-03","type":"deal","source":"Contract Pharma","summary":"Eli Lilly, Radionetics Partner on Novel Radiopharmaceuticals for Cancer - Contract Pharma","headline":"Eli Lilly, Radionetics Partner on Novel Radiopharmaceuticals for Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQWVlLU08tWVdkclNUYkEwdWllcDBHQ1A2S1JPVTJxb3JhSjJVZ24tbHRydWN6WjFlLXF0SmE4eTRUY2RDWE5ZdU4zUmozMnE1TzZCcGljVUFZVjZVb1BsSURPbHBqOVZhbzFvUHBFd2RoLW05Mi1yRHV4UjZLdldyX0hEMG1odTQ?oc=5","date":"2024-07-02","type":"trial","source":"Oncology Pipeline","summary":"Lilly points in a new radiopharma direction | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Lilly points in a new radiopharma direction | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQbVdBUllHWENnR0l6eHFvcU9YQnNheWdWcEJReFVrdW5LWW5WbGpKN055VnF4MDhqaEVCNXQ3Z0hiN1JOQkFTUk1ENi1rcEJoamszRnNiMk5BR0RBeDc2VGlaUUxsU2VwdFNocHQ5cWhER2w1VXJsRzUzVnNnZWVqV01YTGxKd2tvc3pFSmhyT3F1U0ZiYzQySjNiZjd2c19EVExXbUk5QQ?oc=5","date":"2024-07-02","type":"deal","source":"BioSpace","summary":"Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech - BioSpace","headline":"Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPdDUwTGdEcnNqMnZIMlFmN0hjODZyOUNRdHVDdWFDRHNjY1U0NkNpS3gwU1B4dFNqYTdGUzdhUGZIdDdQOUFIUjlQaVJxaUZfNzZZSFhhaVRCdWY2ak1Sdzltc0ZtQXQ2TXFpNk1mUEdta1R5a1B5V1dMVmh2WV9yUW5ScW5uU1BldEVQRFBiN3JHQkdBQjZKV2NNQjNfWkxzdEFxTHVJVlpmOFRsUmYzNlV5eFJBdVd2UFE?oc=5","date":"2024-07-02","type":"deal","source":"Pharmaceutical Technology","summary":"Eli Lilly continues radiopharma push with $140m Radionetics partnership - Pharmaceutical Technology","headline":"Eli Lilly continues radiopharma push with $140m Radionetics partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZzVuUHRfQmJCdE9Ld0M4TVF0RnFOWnFXZ25tVFRfRURNTTdBbnlFUl9PblFueHEwN2FHLXA4dGtFeVc4VE42ekJPdENXeGQteHJ3VHpoZ3BRLXdVdmlsY2xqbzRteElDR3VPc2NCOC16VWtaYWN0Q19kTnR6NG5BQWFuaUp4aUpFU1BGOXpWRENXNFVBSzJqMHhiYVNPeVNlbjhv?oc=5","date":"2024-07-02","type":"deal","source":"PMLiVE","summary":"Eli Lilly and Radionetics Oncology enter $140m radiopharma partnership - PMLiVE","headline":"Eli Lilly and Radionetics Oncology enter $140m radiopharma partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOek42UVM4Q0xtNnhTU2prZExVbmI1TGg2dk9sTjZwS21iTEQ4OGdKbjB2RFZjQUhCcHVpZFN5ck9SMThRcm9rcDNCZ0JTcVlaaS16VGtnRGhVeEJrNjRlaHBHSzItaDRRellWcVdqSVVDenFuVmtwT0RFRHllQmNOSDBn?oc=5","date":"2024-07-02","type":"deal","source":"pharmaphorum","summary":"Lilly builds in radiopharma with $140m Radionetics deal - pharmaphorum","headline":"Lilly builds in radiopharma with $140m Radionetics deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPTGl5YThteXVXREtZSGZZRWg0Mmx1YlhabTVaT054amczWTBUbFNVLXMtamx4VjNaekxJcmVOTGZ6NncwS1BadmpNTmJpRzV5NldWRUVpdkI0cEptZ2FnemVNdXZVNVdFbmk1RW1WcVdhc2xWeHl6UjFsZUxvcHhsaUQ2Nlg3VGtPYjU4bGhKTHhrR3YwWDRjUWtMUlBrVERRZkE?oc=5","date":"2024-07-01","type":"pipeline","source":"MedCity News","summary":"Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects - MedCity News","headline":"Eli Lilly Puts $1B on the Line to Expand its Cancer Radiopharmaceuticals Prospects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPYkUyN3g2TGZvZkxDcTRuMDBrOUlSaUZwVEctbnY1VV82aFpSOFY4dFdETHJoQ2hWcTYtRGhqVWNmRTV1cEt4NGNKRzhLNTMzcnNqMGVuaHRYblN0UTdiNExad0VsYlpZeWlQTlVUU1hXRWdJbzVVRW1XcVBxMkYzaVpGQWNhaG9uMy16SzJlN282QU9Qdi14Rm1qWW9iUQ?oc=5","date":"2024-07-01","type":"deal","source":"BioPharma Dive","summary":"Eli Lilly inks another radiopharma deal, gaining option to buy startup - BioPharma Dive","headline":"Eli Lilly inks another radiopharma deal, gaining option to buy startup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNNDU3eVpRdk94TUFEWUpYZW8yODdoc1RtSkQ4TDV6c1lka1ZLamNkTThoVE5Ncms2OHFwV1BvbkcxN1JTeFJjbkkwVWJpR1JLV2dLVk54OXpBVWt0NTVqc216VUNQdjAyNExCbzl1MGhDQWkxS0xRYzZUekwyMFlZSTRleVBFaktpWnlndkhXSWlmaTJrT3lvMTRESnpBZWFYUTZLbTRaTEgzQlZ4Z2UtOA?oc=5","date":"2024-07-01","type":"deal","source":"Fierce Biotech","summary":"Lilly signs $140M upfront partnership with Radionetics in latest radiopharma play - Fierce Biotech","headline":"Lilly signs $140M upfront partnership with Radionetics in latest radiopharma play","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxPNTVMSmk1NnplcUFJM0FVbk9NNW1Ed1NDSmtPRDJ5RXpzODRyYUpSc2V3UGN4VWdIazhNLTE4SUFxRGdsTGp5YXFWUzR4ajEtRFkwZG1jYlBCNjBNRWhqN2o4M2lIaElMcDhTblBwN2pWTTNyWWsxRmR4R09zZmw0VzI4LWtETjYwSk05VXc3VUtRU2FkMzNSVFotazdxSTllVHlneW81bF95aVVNb0toS0JNdlhXbGlJc3A1dXQzdU10ci1FMnYxRXdHdFpRUHhUVnNVdUJFWldydXJWQUpjUWtwRHY2TWFwd2ItNmJjblc2NklaTFFBQnRpYnRKSFZWa2x1TUx5V3lSRzlRcEd3MjFqcDNleVdHZ0ZQTXB2dGpNT1dKbUJwZlBNM1p2NFJic1h0NmJyN3BKa1Y5d0tmZDJvTDdJX3dpdGRsa0VtRmJZSDQ?oc=5","date":"2024-01-03","type":"pipeline","source":"Business Wire","summary":"Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces the Appointment of Industry Leader, Paul Grayson, as CEO - Business Wire","headline":"Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNN252UkNpWWFyWkVzbXdzSTZ5RTg1UmZXcDBNeVlRZ2haZkl2UTNTVndOeGkzcjhVc1dqcVNkVXVmS3ZlM1NTX0ZVS1p3aWJ1aWdIeWtsU3VrS3JZNDVWX0V1cXFmMm5CRUliVkd3OEhlV0dWczdZWi05RWxEWHVYblhtOHU?oc=5","date":"2023-02-23","type":"deal","source":"Medical Buyer","summary":"Radionetics Oncology appoints Istvan Molnar as CMO - Medical Buyer","headline":"Radionetics Oncology appoints Istvan Molnar as CMO","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}